Patents by Inventor James J. La Clair

James J. La Clair has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230029301
    Abstract: Disclosed herein, inter alia, are methods of making polyketide compounds.
    Type: Application
    Filed: August 5, 2020
    Publication date: January 26, 2023
    Inventors: Michael D. Burkart, Warren C. Chan, Brian Leon, James J. La Clair, Kelsey A. Trieger
  • Publication number: 20220227742
    Abstract: Provided herein, inter alia, are splice modulator compounds. The compounds include optically pure, stereospecific analogs of FD-895. The methods provided herein allow, for example, for scalable preparation of said compounds, and further allow, for example, use of said compounds for inhibiting spliceosome activity.
    Type: Application
    Filed: January 12, 2022
    Publication date: July 21, 2022
    Inventors: Michael D. Burkart, Warren C. Chan, James J. La Clair, Kelsey A. Trieger, Catriona Jamieson
  • Patent number: 11203588
    Abstract: There are provided inter alia stable anti-cancer compounds and splice modulators and methods of synthesis and use thereof.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: December 21, 2021
    Assignee: The Regents of the University of California
    Inventors: Michael D. Burkart, James J. La Clair, Sachin Dhar, Justin C. Hammons, Brian Leon
  • Publication number: 20200299671
    Abstract: A halogenation system, a method of halogenating a substrate, and halogenated compounds are provided. The halogenation system includes PltM immobilized on a solid support. The system may include one or more additional enzymes immobilized on the solid support. The method of halogenating a substrate includes running the substrate and a reaction solution through the halogenation system including PltM immobilized on a solid support. The halogenated compounds include 4,6-diCl-3, 4,6-diCl-8, 2,4-diCl-9, 2,6-diCl-11, 3,5-diCl-15, 4,6-diCl-16, 4,6-diCl-18, 4-Cl-23, and/or 4,6-diBr-3.
    Type: Application
    Filed: March 19, 2020
    Publication date: September 24, 2020
    Inventors: Sylvie Garneau-Tsodikova, Oleg V. Tsodikov, Shogo Mori, Michael D. Burkart, James J. La Clair
  • Publication number: 20200299279
    Abstract: There are provided inter alia stable anti-cancer compounds and splice modulators and methods of synthesis and use thereof.
    Type: Application
    Filed: March 10, 2017
    Publication date: September 24, 2020
    Inventors: Michael D. BURKART, James J. LA CLAIR, Sachin DHAR, Justin C. HAMMONS
  • Patent number: 10675267
    Abstract: There are provided, inter alia, methods and compositions for diagnosis and treatment of acute myeloid leukemia (AML), secondary acute myeloid leukemia (sAML), and age-related diseases.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: June 9, 2020
    Assignee: The Regents Of The University Of California
    Inventors: Catriona H.m. Jamieson, Leslie C. Robertson, Larisa Balaian, James J. La Clair, Reymundo Villa, Heather Leu, Nathaniel Delos Santos, Michael D. Burkart
  • Publication number: 20180296524
    Abstract: There are provided, inter alia, methods and compositions for diagnosis and treatment of acute myeloid leukemia (AML), secondary acute myeloid leukemia (sAML), and age-related diseases.
    Type: Application
    Filed: September 23, 2016
    Publication date: October 18, 2018
    Inventors: Catriona H.m. Jamieson, Leslie C. Robertson, Larisa Balaian, James J. La Clair, Reymundo Villa, Heather Leu, Nathaniel Delos Santos, Michael D. Burkart
  • Patent number: 9604973
    Abstract: Provided herein, inter alia, are anticancer polyketides. The uses of the polyketides described herein include treatment of cancer, for example, through regulation of the spliceosome and detection of spliceosome inhibition.
    Type: Grant
    Filed: September 26, 2014
    Date of Patent: March 28, 2017
    Assignee: The Regents of the University of California
    Inventors: Michael D. Burkart, James J. La Clair, Brian D. Jones, Alexander Mandel, Reymundo Villa, Januario E. Castro, Manoj Kumar Kashyap, Deepak Kumar
  • Patent number: 9481662
    Abstract: There are provided, inter alia, derivatives of seriniquinone and methods useful for the treatment of cancer, and in particular treatment of melanoma and prostate cancer.
    Type: Grant
    Filed: January 27, 2015
    Date of Patent: November 1, 2016
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: William Fenical, Paul R. Jensen, James J. La Clair, Lynnie Trzoss, Takashi Fukuda
  • Publication number: 20150148314
    Abstract: There are provided, inter alia, derivatives of seriniquinone and methods useful for the treatment of cancer, and in particular treatment of melanoma and prostate cancer.
    Type: Application
    Filed: January 27, 2015
    Publication date: May 28, 2015
    Inventors: William Fenical, Paul R. Jensen, James J. La Clair, Lynnie Trzoss, Takashi Fukuda
  • Publication number: 20150133535
    Abstract: Provided herein, inter alia, are anticancer polyketides. The uses of the polyketides described herein include treatment of cancer, for example, through regulation of the spliceosome and detection of spliceosome inhibition.
    Type: Application
    Filed: September 26, 2014
    Publication date: May 14, 2015
    Inventors: Michael D. Burkart, James J. La Clair, Brian D. Jones, Alexander Mandel, Reymundo Villa, Januario E. Castro, Manoj Kumar Kashyap, Deepak Kumar
  • Patent number: 8653283
    Abstract: The present disclosure relates generally to compositions and methods for treating cancer. In some aspects, novel spirohexenolides and methods of using and producing them are described.
    Type: Grant
    Filed: April 16, 2010
    Date of Patent: February 18, 2014
    Assignee: The Regents of The University of California
    Inventors: Michael D. Burkart, James J. La Clair, MinJin Kang, Brian D. Jones, Alexander L. Mandel, Wei-Luen Yu, Justin C. Hammons
  • Publication number: 20120083527
    Abstract: The present disclosure relates generally to compositions and methods for treating cancer. In some aspects, novel spirohexenolides and methods of using and producing them are described.
    Type: Application
    Filed: April 16, 2010
    Publication date: April 5, 2012
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Michael D. Burkart, James J. La Clair, Minjin Kang, Brian D. Jones, Alexander L. Mandel, Wei-Luen Yu, Justin C. Hammons
  • Patent number: 7706984
    Abstract: The invention relates to a device and a method for analyzing the interaction between one or more molecular species the method comprising the steps of creating streams of digital data, transferring the stream of digital data through a substrate, manipulating the molecular structure of the substrate by adding or subtracting molecules or groups of molecules to be examined to or from the substrate, receiving the streams of digital data transferred through the substrate, decoding the identity of an examined molecule or group of molecules interacting with the substrate by deciphering how the molecules affinity to another molecule or group of molecules or molecular sensor or group of molecular sensors alters the stream of digital data. The invention relates further to a method for identifying molecular species, and to a device for identifying molecular species and to a substrate for analyzing the interaction and for identifying molecular species.
    Type: Grant
    Filed: March 10, 2004
    Date of Patent: April 27, 2010
    Assignee: The Regents of the University of California
    Inventor: James J. La Clair
  • Publication number: 20080241943
    Abstract: A fluorescent dye-doped crystalline assay is employed for selection and detection of thiophilic heavy metal ions. While comparable in analytical performance to known solution based methodologies, the formation of crystalline analytes provides for signal amplification, and consequently, a powerful platform whose analysis is directly amenable to high-throughput video capture systems. In a microcapillary format, this assay is capable of screening hundreds of samples per day for the presence of subnanomolar concentrations of Hg2+ using a conventional fluorescence microscope.
    Type: Application
    Filed: November 18, 2005
    Publication date: October 2, 2008
    Applicant: The Scripps Research Institute
    Inventors: Kim D. Janda, Tobin J. Dickerson, James J. La Clair
  • Publication number: 20040229254
    Abstract: The invention relates to a device and a method for analyzing the interaction between one or more molecular species the method comprising the steps of creating streams of digital data, transferring the stream of digital data through a substrate, manipulating the molecular structure of the substrate by adding or subtracting molecules or groups of molecules to be examined to or from the substrate, receiving the streams of digital data transferred through the substrate, decoding the identity of an examined molecule or group of molecules interacting with the substrate by deciphering how the molecules affinity to another molecule or group of molecules or molecular sensor or group of molecular sensors alters the stream of digital data. The invention relates further to a method for identifying molecular species, and to a device for identifying molecular species and to a substrate for analysing the interaction and for identifying molecular species.
    Type: Application
    Filed: March 10, 2004
    Publication date: November 18, 2004
    Applicant: The Regents of the University of California
    Inventor: James J. La Clair